Roche Holding AG (OTCMKTS:RHHBY) Holdings Decreased by OLD National Bancorp IN

OLD National Bancorp IN reduced its stake in shares of Roche Holding AG (OTCMKTS:RHHBY) by 3.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 255,067 shares of the company’s stock after selling 9,889 shares during the quarter. OLD National Bancorp IN’s holdings in Roche were worth $8,989,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Bard Financial Services Inc. raised its position in Roche by 37.7% in the fourth quarter. Bard Financial Services Inc. now owns 110,850 shares of the company’s stock worth $3,866,000 after acquiring an additional 30,350 shares in the last quarter. GAMMA Investing LLC raised its position in Roche by 57.7% in the third quarter. GAMMA Investing LLC now owns 7,944 shares of the company’s stock worth $317,000 after acquiring an additional 2,906 shares in the last quarter. Diversified Trust Co increased its stake in Roche by 6.4% in the 3rd quarter. Diversified Trust Co now owns 59,742 shares of the company’s stock worth $2,396,000 after purchasing an additional 3,613 shares in the last quarter. Norman Fields Gottscho Capital Management LLC increased its stake in Roche by 5.5% in the 3rd quarter. Norman Fields Gottscho Capital Management LLC now owns 26,000 shares of the company’s stock worth $1,039,000 after purchasing an additional 1,350 shares in the last quarter. Finally, Canopy Partners LLC increased its stake in Roche by 4.6% in the 3rd quarter. Canopy Partners LLC now owns 7,772 shares of the company’s stock worth $310,000 after purchasing an additional 344 shares in the last quarter.

Roche Trading Down 0.2 %

Shares of RHHBY opened at $38.86 on Thursday. The business’s 50-day moving average price is $35.98 and its 200 day moving average price is $38.23. Roche Holding AG has a 1-year low of $29.20 and a 1-year high of $42.43. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.26 and a quick ratio of 0.97.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.